These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 8874380)

  • 21. Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study.
    Brustmann H
    Gynecol Oncol; 2005 Sep; 98(3):396-402. PubMed ID: 16005054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Phenotype--genotype--correlation in ovarian neoplasia].
    Diebold J
    Verh Dtsch Ges Pathol; 2001; 85():153-60. PubMed ID: 11894392
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma?
    Fukumoto M; Nakayama K
    Pathol Int; 2006 May; 56(5):233-9. PubMed ID: 16669871
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The proliferative activity of ovarian tumors of low malignant potential differs from that of ovarian carcinoma.
    Nakayama K; Takebayashi Y; Hata K; Fujiwaki R; Iida K; Fukumoto M; Miyazaki K
    Anticancer Res; 2003; 23(6C):4657-62. PubMed ID: 14981910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of extracellular matrix proteins in ovarian serous tumors.
    Salani R; Neuberger I; Kurman RJ; Bristow RE; Chang HW; Wang TL; Shih IeM
    Int J Gynecol Pathol; 2007 Apr; 26(2):141-6. PubMed ID: 17413980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA fragmentation factor (DFF45): expression and prognostic value in serous ovarian cancer.
    Brustmann H
    Pathol Res Pract; 2006; 202(10):713-20. PubMed ID: 16962250
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sjögren's syndrome and MALT lymphomas of salivary glands: a DNA-cytometric and interphase-cytogenetic study.
    Ihrler S; Baretton GB; Menauer F; Blasenbreu-Vogt S; Löhrs U
    Mod Pathol; 2000 Jan; 13(1):4-12. PubMed ID: 10658904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
    Brustmann H
    Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
    Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
    Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interphase fluorescence in situ hybridization studies of ovarian adenocarcinomas using the midisatellite probe.
    Kalir T; Eisberg A; Dottino P; Cohen C
    Gynecol Oncol; 1999 Feb; 72(2):208-14. PubMed ID: 10021303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphatic vascular invasion in ovarian serous tumors of low malignant potential with stromal microinvasion: a case control study.
    Sangoi AR; McKenney JK; Dadras SS; Longacre TA
    Am J Surg Pathol; 2008 Feb; 32(2):261-8. PubMed ID: 18223329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interphase cytogenetic analysis of prostatic carcinomas by use of nonisotopic in situ hybridization.
    Baretton GB; Valina C; Vogt T; Schneiderbanger K; Diebold J; Löhrs U
    Cancer Res; 1994 Aug; 54(16):4472-80. PubMed ID: 8044798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
    Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
    Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
    Mayr D; Hirschmann A; Löhrs U; Diebold J
    Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of chromosomal changes in serous ovarian carcinoma using high-resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease.
    Kim SW; Kim JW; Kim YT; Kim JH; Kim S; Yoon BS; Nam EJ; Kim HY
    Genes Chromosomes Cancer; 2007 Jan; 46(1):1-9. PubMed ID: 17044060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma.
    Salvador S; Rempel A; Soslow RA; Gilks B; Huntsman D; Miller D
    Gynecol Oncol; 2008 Sep; 110(3):408-17. PubMed ID: 18597838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genomic alterations in fallopian tube carcinoma: comparison to serous uterine and ovarian carcinomas reveals similarity suggesting likeness in molecular pathogenesis.
    Pere H; Tapper J; Seppälä M; Knuutila S; Butzow R
    Cancer Res; 1998 Oct; 58(19):4274-6. PubMed ID: 9766651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Copy number aberrations in benign serous ovarian tumors: a case for reclassification?
    Hunter SM; Anglesio MS; Sharma R; Gilks CB; Melnyk N; Chiew YE; deFazio A; ; Longacre TA; Huntsman DG; Gorringe KL; Campbell IG
    Clin Cancer Res; 2011 Dec; 17(23):7273-82. PubMed ID: 21976534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.